US Broker Ratings

Elanco Animal Health (ELAN) Stock Analysis: A 19.43% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) has emerged as a noteworthy player within the healthcare sector, specifically in the drug manufacturing niche for specialty and generic..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 41% Potential Upside Beckons Investors

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors as it navigates the..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Unveils 75% Upside Potential

Telix Pharmaceuticals Limited (TLX), a burgeoning force in the biotechnology sector, is capturing investor attention with its promising growth trajectory and substantial upside potential. With a..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 29.48% Potential Upside in the Biotech Sphere

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is attracting investor attention with its potential upside of 29.48%. With a current stock..

ADMA Biologics Inc (ADMA) Stock Analysis: High Potential Upside Amid Robust Growth Trends

ADMA Biologics Inc (NASDAQ: ADMA), a pioneering player in the biotechnology sector, is poised for substantial growth, offering a remarkable potential upside of 96.65%. This healthcare..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Navigating Growth with High Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, stands out with its strategic focus on developing innovative treatments for B-cell mediated diseases...

Grifols, S.A. (GRFS) Stock Analysis: A 51.75% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, is drawing attention from investors with its substantial potential upside of 51.75%, as indicated by..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Market Uncertainties with a Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a forward-thinking healthcare technology company, is catching the attention of investors with its dynamic approach to health plans and technology solutions...

Incyte Corporation (INCY) Stock Analysis: Navigating Growth with a Robust Pipeline and Strong Revenue Growth

For investors eyeing the healthcare sector, Incyte Corporation (NASDAQ: INCY) presents a compelling opportunity, primarily driven by its robust revenue growth and impressive return on equity...

Guardant Health, Inc. (GH) Stock Analysis: A Promising Path in Precision Oncology Despite Financial Hurdles

Guardant Health, Inc. (NASDAQ: GH) is carving out a significant niche in the healthcare sector, specifically within diagnostics and research. Headquartered in Palo Alto, California, this..

Prestige Consumer Healthcare (PBH) Stock Analysis: Understanding Its 35% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity for investors seeking to capitalize on a niche player in the healthcare sector. With a market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A High-Potential Biotech with Robust Revenue Growth and Strategic Therapeutic Pipeline

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector with its impressive market cap of $11.06 billion. The company’s innovative approach to genetic..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings and Promising 41.2% Revenue Growth Propel Market Confidence

Glaukos Corporation (NYSE: GKOS), a pivotal player in the healthcare sector specializing in medical devices, continues to capture investor attention with its robust growth prospects and..

Neurocrine Biosciences, Inc. (NBIX): Analyst Consensus and Growth Potential with a 12% Upside

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, has captured investor attention with its robust growth prospects and a promising 12.47% potential upside..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Contender with 22% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its promising position in the biotechnology sector. Specializing in the treatment of rare neuroendocrine diseases, Rhythm..

Cytokinetics, Incorporated (CYTK)

⚠️ No article content returned.

..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential Upside Amidst Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company headquartered in London, is making waves in the healthcare sector with its innovative approach to drug development...

Gilead Sciences, Inc. (GILD) Stock Analysis: Unlocking a 20% Potential Upside for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector, remains a compelling investment opportunity within the drug manufacturing industry. With a market capitalization of..

West Pharmaceutical Services, Inc. (WST): Analyst Consensus Highlights Growth Amidst a Robust Market Position

West Pharmaceutical Services, Inc. (NYSE: WST) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a substantial market..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unveiling Growth Potential in the Eye Health Sector

For investors looking to delve into the healthcare sector, Bausch + Lomb Corporation (NYSE: BLCO) presents a compelling opportunity. With a focus on eye health, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds